Ron Cohen has defied Venture Capital wisdom by founding Acorda Therapeutics over 20 years ago and remaining the CEO to this day. Originally hearing “no” from 70 VCs, he nevertheless grew the company into a public biotech worth nearly $2B today. As unlikely as that has been, there would’ve been no Acorda had he found more success on Broadway.
Ron discusses his road from Jeopardy! champion to entrepreneur, the role played by his flat head and great hair, and what on earth could motivate someone to invest in drug development. He also explains how upstate NY does not start at 96th St.
The two-part interview continues in the following episode, Part 2.